We’re Listening! Client FAQs

As one of the nation’s premier PBMs, WellDyneRx is extremely fortunate to have built such a robust array of unique clinical and cost containment programs as seen in our WellManaged programs. As a whole, they allow us to do two things: one, provide outstanding service to both clients and members. And two, they boost our ability to be flexible so we can give our clients the strategic business advantages they need to be successful.

All of this is important to note because we frequently get asked the same questions by our clients, often around issues addressed by our umbrella of WellManaged programs. So, for the purpose of this article, we thought it would be helpful to highlight a few of those questions and show how our WellManaged–Clinical and WellManaged–Formulary Programs help to answer them.

Question:

How do you manage your plan spend and address the growing cost of specialty medications?

Answer:

WellDyneRx’s patented Intercept Shared Savings Program helps clients control specialty spend by shifting drug
costs to other payment avenues.

  • Clients achieve a net effective AWP discount of 30%
  • Clients realize a $512 lower cost per specialty drug
  • Clients realized savings of $45.05 PMPY
  • Saved clients over $15 million in 2017

Question:

What is the potential savings for the plan/member and the potential disruption to the member?

Answer:

Our WellManaged–Formulary Program brings the most balanced benefit design to the market, with formulary choice as its foundation. WellManaged programs help to positively influence total healthcare costs by managing unit cost of prescriptions with Prior Authorizations (PAs), Quantity Limits (QLs), and step edits.

  • Member engagement to promote quality of care through our full suite of programs
  • Diabetes
  • Respiratory
  • Opioids
  • Hepatitis C

As far as disruption to our members, we point to this fact: US Specialty Care has been recognized as the specialty
pharmacy with the highest patient satisfaction ratings across the United States for two years in a row.

Question:

What are you doing in regard to the opioid epidemic?

Answer:

Our WellManaged–Opiods Program takes a comprehensive approach to addressing this growing problem.

  • Maintaining access to opioid medications while prioritizing patient safety and controlling costs.
  • Real time point of service (POS) cumulative morphine equivalent dose (MED) edits
  • Prior Authorization for targeted high-risk medications
  • Proprietary risk stratification evaluation
  • Physician communication on at-risk members
  • Cancer, end-of life care, or hospice patients are excluded

Do you have more questions? Let us know!


2018 Quarter Two WellInformed Table Contents